Safety across the full program was consistently favorable: adverse events, primarily mild headache and gastrointestinal symptoms, occurred at rates comparable to placebo, with no treatment-related discontinuations, no IGF-1 elevation, and no impact on glucose metabolism
Prioritize fiber-rich foods like veggies, fruit, and whole grains
doi: 10.1002/mnfr.201100128
For injectable semaglutide, doses start at 0.25 mg per week and may increase to a maximum of 2 mg (Ozempic) or 2.4 mg (Wegovy) weekly. For oral semaglutide (Rybelsus), doses start at 3 mg daily and increase to a maximum of 14 mg
#Healthcare #Biotech #Pharmaceuticals #Diabetes #Obesity #Innovation #ClinicalTrials To view or add a comment, sign in Anti-Obesity Drugs 1 Appetite Suppressants (Central Acting Agents) Mechanism: Reduce appetite Increase satiety Act on CNS (hypothalamus) Examples: Phentermine Phentermine + Topiramate Bupropion + Naltrexone 2 GLP-1 Receptor Agonists Mechanism: Increase insulin secretion Delay gastric emptying Promote satiety Examples: Liraglutide Semaglutide 3 Dual GIP & GLP-1 Agonist Example: Tirzepatide 4 Fat Absorption Inhibitors Mechanism: Inhibit pancreatic lipase Reduce dietary fat absorption Examples: Orlistat Cetilistat 5 Other / Adjunct Drugs Metformin (used in insulin resistance) Zonisamide (off-label) Therapeutic Effects Decrease appetite Increase fullness Reduce fat absorption Promote weight loss Improve metabolic parameters Important Note Lifestyle modification (diet + exercise) is essential along with medication
Is this bundle dairy-free
